Yüksel Meltem Kurt, İlhan Osman
Ankara University, School of Medicine Hematology, Department and Bone Marrow Transplantation Unit, Turkey.
Transfus Apher Sci. 2018 Apr;57(2):153-158. doi: 10.1016/j.transci.2018.04.012. Epub 2018 Apr 18.
Hematopoietic Stem Cell Transplantation (HSCT) is a well estabished treatment modality for patients with severe disorders of the hematopoietic system. HSCT is the pioneer of not the adoptive immunotherapy but also cellular therapies. It was first performed in 1957; since then the transplantation numbers have increased every year in almost all parts of the World. However, the increase in the quality of this procedure was not as fast as the numbers. The first Standards for hematopoeietic cell collection, processing and transplantation in Europe was established in 1998 by the European Group for Bone Marrow Transplantation (EBMT) and The International Society for Hematotherapy and Graft Engineering Europe I (SHAGE Europe) and the Joint Accreditation Committee of ISCT EBMT (JACIE) was founded. JACIE is a non-profit voluntary organization that helps all the stakeholders of HSCT, the teams, goverments, regulators, payers and, mostly, the patients. In this review the aims and the twenty years history of JACIE in the World and in Turkey is explained.
造血干细胞移植(HSCT)是治疗严重造血系统疾病患者的一种成熟治疗方式。HSCT不仅是过继性免疫疗法的先驱,也是细胞疗法的先驱。它于1957年首次开展;从那时起,全球几乎所有地区的移植数量每年都在增加。然而,该程序质量的提升速度不如数量增长快。1998年,欧洲骨髓移植组(EBMT)、国际血液治疗与移植工程学会欧洲分会I(SHAGE Europe)制定了欧洲首个造血细胞采集、处理和移植标准,国际细胞治疗学会-欧洲骨髓移植组联合认证委员会(JACIE)成立。JACIE是一个非营利性志愿组织,它为HSCT的所有利益相关者提供帮助,包括团队、政府、监管机构、付款方,尤其是患者。在这篇综述中,将解释JACIE在全球及土耳其的目标和二十年历史。